View in EDS

Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.

Saved in:
Bibliographic Details
Title: Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
Authors: Apolo A; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Baumann BC; Department of Radiation Oncology, Springfield Clinic, Springfield, IL, USA.; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Genitourinary Pathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ballas L; Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA., Bangs R; Patient Advocate, Bladder Cancer Advocacy Network, Bethesda, MD, USA., Brothers K; Patient Advocate, National Cancer Institute Bladder Cancer Task Force, Rockville, MD, USA., Greenberg SC; Patient Advocate, National Cancer Institute Bladder Cancer Task Force, Rockville, MD, USA.; Patient Advocate, Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA., Delacroix S; Department of Urology, Louisiana State University Health Science Center, New Orleans, New Orleans, LA, USA., Dignam JJ; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Feldman AS; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Foster JC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA., Hahn NM; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Hansel DE; Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hoffman-Censits J; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamran SC; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA., Lipman R; Patient Advocate, Bladder Cancer Advocacy Network, Bethesda, MD, USA., Mann B; Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Rockville, MD, USA., McConkey D; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA., McKiernan J; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA, Department of Urology, Columbia University, New York, NY, USA., Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Smith AB; Department of Urology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Tangen C; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Amiri AT; Coordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA., Weinstock C; Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., West PJ; Emmes Company, Rockville, MD, USA., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Source: Bladder cancer (Amsterdam, Netherlands) [Bladder Cancer] 2025 Feb 24; Vol. 11 (1), pp. 23523735251319185. Date of Electronic Publication: 2025 Feb 24 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: IOS Press Country of Publication: United States NLM ID: 101668567 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3735 (Electronic) Linking ISSN: 23523727 NLM ISO Abbreviation: Bladder Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40034245
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<superscript />.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Apolo+A%22">Apolo A</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Baumann+BC%22">Baumann BC</searchLink>; Department of Radiation Oncology, Springfield Clinic, Springfield, IL, USA.; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Al-Ahmadie+H%22">Al-Ahmadie H</searchLink>; Department of Pathology and Laboratory Medicine, Genitourinary Pathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ballas+L%22">Ballas L</searchLink>; Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bangs+R%22">Bangs R</searchLink>; Patient Advocate, Bladder Cancer Advocacy Network, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brothers+K%22">Brothers K</searchLink>; Patient Advocate, National Cancer Institute Bladder Cancer Task Force, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Greenberg+SC%22">Greenberg SC</searchLink>; Patient Advocate, National Cancer Institute Bladder Cancer Task Force, Rockville, MD, USA.; Patient Advocate, Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Delacroix+S%22">Delacroix S</searchLink>; Department of Urology, Louisiana State University Health Science Center, New Orleans, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Dignam+JJ%22">Dignam JJ</searchLink>; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Efstathiou+JA%22">Efstathiou JA</searchLink>; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Feldman+AS%22">Feldman AS</searchLink>; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Foster+JC%22">Foster JC</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hahn+NM%22">Hahn NM</searchLink>; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hall+E%22">Hall E</searchLink>; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Hansel+DE%22">Hansel DE</searchLink>; Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hoffman-Censits+J%22">Hoffman-Censits J</searchLink>; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kamat+AM%22">Kamat AM</searchLink>; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kamran+SC%22">Kamran SC</searchLink>; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Khani+F%22">Khani F</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lerner+SP%22">Lerner SP</searchLink>; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lipman+R%22">Lipman R</searchLink>; Patient Advocate, Bladder Cancer Advocacy Network, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mann+B%22">Mann B</searchLink>; Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22McConkey+D%22">McConkey D</searchLink>; Departments of Oncology and Urology, Johns Hopkins University, Greenberg Bladder Cancer Institute, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22McKiernan+J%22">McKiernan J</searchLink>; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA, Department of Urology, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rose+TL%22">Rose TL</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Smith+AB%22">Smith AB</searchLink>; Department of Urology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Tangen+C%22">Tangen C</searchLink>; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Amiri+AT%22">Amiri AT</searchLink>; Coordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Weinstock+C%22">Weinstock C</searchLink>; Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22West+PJ%22">West PJ</searchLink>; Emmes Company, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Milowsky+MI%22">Milowsky MI</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Black+PC%22">Black PC</searchLink>; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101668567%22">Bladder cancer (Amsterdam, Netherlands)</searchLink> [Bladder Cancer] 2025 Feb 24; Vol. 11 (1), pp. 23523735251319185. <i>Date of Electronic Publication: </i>2025 Feb 24 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22IOS+Press%22">IOS Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101668567 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3735 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523727%22">23523727 </searchLink><i>NLM ISO Abbreviation: </i>Bladder Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40034245
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/23523735251319185
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 23523735251319185
    Titles:
      – TitleFull: Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Apolo A
      – PersonEntity:
          Name:
            NameFull: Baumann BC
      – PersonEntity:
          Name:
            NameFull: Al-Ahmadie H
      – PersonEntity:
          Name:
            NameFull: Ballas L
      – PersonEntity:
          Name:
            NameFull: Bangs R
      – PersonEntity:
          Name:
            NameFull: Brothers K
      – PersonEntity:
          Name:
            NameFull: Greenberg SC
      – PersonEntity:
          Name:
            NameFull: Delacroix S
      – PersonEntity:
          Name:
            NameFull: Dignam JJ
      – PersonEntity:
          Name:
            NameFull: Efstathiou JA
      – PersonEntity:
          Name:
            NameFull: Feldman AS
      – PersonEntity:
          Name:
            NameFull: Foster JC
      – PersonEntity:
          Name:
            NameFull: Hahn NM
      – PersonEntity:
          Name:
            NameFull: Hall E
      – PersonEntity:
          Name:
            NameFull: Hansel DE
      – PersonEntity:
          Name:
            NameFull: Hoffman-Censits J
      – PersonEntity:
          Name:
            NameFull: Kamat AM
      – PersonEntity:
          Name:
            NameFull: Kamran SC
      – PersonEntity:
          Name:
            NameFull: Khani F
      – PersonEntity:
          Name:
            NameFull: Lerner SP
      – PersonEntity:
          Name:
            NameFull: Lipman R
      – PersonEntity:
          Name:
            NameFull: Mann B
      – PersonEntity:
          Name:
            NameFull: McConkey D
      – PersonEntity:
          Name:
            NameFull: McKiernan J
      – PersonEntity:
          Name:
            NameFull: Rose TL
      – PersonEntity:
          Name:
            NameFull: Smith AB
      – PersonEntity:
          Name:
            NameFull: Tangen C
      – PersonEntity:
          Name:
            NameFull: Amiri AT
      – PersonEntity:
          Name:
            NameFull: Weinstock C
      – PersonEntity:
          Name:
            NameFull: West PJ
      – PersonEntity:
          Name:
            NameFull: Milowsky MI
      – PersonEntity:
          Name:
            NameFull: Black PC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2025 Feb 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3735
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Bladder cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1